Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 20

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 20
---
 you should carefully consider all of the information in this prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page16.​​​Nasdaq Capital Market symbolOur common stock is listed on the Nasdaq Capital Market under the symbol “MBIO”.​There is no established public trading market for the Warrants and pre-funded warrants, and we do not expect a market to develop. We do not intend to apply for listing of the Warrants or pre-funded warrants on any securities exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the Warrants and pre-funded warrants will be limited.
14

The number of shares of our common stock to be outstanding after this offering is based on 64,768,830 shares of our stock outstanding as of January 10, 2025, and excludes:

| ● | 76,112 shares of our common stock issuable upon the exercise of outstanding stock options as of January 10, 2025, with a weighted-average exercise price of $85.95 per share; |

| ● | 11,176 shares of common stock issuable upon the vesting and settlement of outstanding restricted stock units as of January 10, 2025; |

| ● | 78,847,300 shares of our common stock issuable upon the exercise of outstanding warrants as of January 10, 2025, with a weighted-average exercise price of $0.29 per share; |

| ● | 56,359 shares of our common stock issuable upon conversion of the Class A Common Stock, at the holders’ election; |

| ● | 16,666 shares of our common stock issuable upon conversion of the Class A Preferred Stock, at the holders’ election; |

| ● | 398,614 shares of our common stock reserved for future issuance under the Mustang Bio, Inc. 2016 Equity Incentive Plan, as amended (the “2016 Plan”), plus any future increases in the number of shares of common stock reserved for issuance thereunder; and |

| ● | 338,315 shares of our common stock reserved for future issuance under the Mustang Bio, Inc. 2019 Employee Stock Purchase Plan, as amended (the “ESPP”), plus any future increases, including annual automatic evergreen increases, in the number of shares of common stock reserved for issuance thereunder. |

Unless otherwise indicated, all information contained in this prospectus assumes:

| ● | no